Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/22/2022
NHSA: Further Reduction of Drug and Medical Consumable Prices to Secur...
12/21/2022
BioNTech Sends First Batch of Vaccine to China for German Residents Th...
12/19/2022
Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4...
12/13/2022
China to Roll Out Second COVID Vaccine Booster for High-risk Groups, E...
12/9/2022
China Cracks Down on Drug Price Gouging amid Fears of COVID Spike: Reu...
12/8/2022
China's Reversal of Zero-Covid Policy to Boost Its Healthcare Sector: ...
12/6/2022
Summit and Akeso Reached ~$5B In-License Deal for Breakthru Innovative...
11/30/2022
NMPA Issues the List of Drugs Prohibited for Online Sales (Unofficial ...
11/30/2022
NMPA Issues the Announcement on Regulating the Filing and Reporting of...
11/22/2022
Measures for Supervision and Administration of Online Sales of Drugs: ...
11/17/2022
Marinus Pharma and Tenacia Biotech Tie Up for Ganaxolone Development ...
11/15/2022
WuXi Vaccines Buys Harbour BioMed China Facility
11/14/2022
BioNTech and Fosun Pharma Receive Special Approvals for Omicron-BA.4/B...
11/11/2022
NMPA Announces Package Insert Revision of Phloroglucinol Injection
11/6/2022
China to Approve BioNTech's Covid-19 Vaccine for Foreigners with Pathw...
11/4/2022
China Clarifies Regulations for Online Prescription Drug Sales, But Th...
11/3/2022
NMPA Releases the Draft List of Drugs Prohibited for Online Sales for ...
10/26/2022
CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
10/19/2022
The Emergence of Commercial Health Insurances as An Access Route to th...
10/12/2022
Cracking the Code to Commercial Promise in Asia (PharmExec)
10/9/2022
CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
10/6/2022
AIM Vaccine Launches IPO on the Main Board of SEHK
10/6/2022
Telemedicine Expanded to Rural China: Across the Divide
10/4/2022
Moderna Refuses Chinese Request to Hand Over mRNA Technology, Risking ...
9/28/2022
Qiming Venture: 'Overinvested' China Healthcare Sector Set for Shake U...
9/27/2022
Legend's Carvykti Wins Japanese Approval for Relapsed or Refractory M...
9/22/2022
Moderna 'Eager' to Collaborate with China on Supplying COVID Vaccines
9/16/2022
Competition Intensifies as More Chinese Regions Embarks on Free HPV Va...
9/2/2022
SAMR Issues New Regulation on Online Drug Sales (with Summary)
8/31/2022
BCG Report: Chinese Vaccine Sector under Restructure - Opportunities a...
Page:
8
/
72
Total number of articles:
2132
:
[First]
[<<]
[6]
[7]
[8]
[9]
[10]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit